Cited by 1,617HIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHIV Research and Treatment

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Open access

Kuller, Lewis H, Tracy, Russell, Belloso, Waldo, Wit, Stephane De, Drummond, Fraser, Lane, H. Clifford, Ledergerber, Bruno, Lundgren, Jens, Neuhaus, Jacqueline, Nixon, Daniel, Paton, Nicholas I, Neaton, James D, for the INSIGHT SMART Study Group·2008·PLoS Medicine

DOI 10.1371/journal.pmed.0050203PMC PMC2570418

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent, CD4-guided antiretroviral treatment (ART) (drug conservation [DC]) than continuous ART (viral suppression [VS]).We hypothesized that increased HIV-RNA levels following ART interruption induced activation of tissue factor pathways, thrombosis, and fibrinolysis. METHODS AND FINDINGS: Stored samples were used to measure six biomarkers: high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), amyloid A, amyloid P, D-dimer, and prothrombin fragment 1+2. Two studies were conducted: (1) a nested case-control study for studying biomarker associations with mortality, and (2) a study to compare DC and VS participants for biomarker changes. For (1), markers were determined at study entry and before death (latest level) for 85 deaths and for two controls (n = 170) matched on country, age, sex, and date of randomization. Odds ratios (ORs) were estimated with logistic regression. For each biomarker, each of the three upper quartiles was compared to the lowest quartile. For (2), the biomarkers were assessed for 249 DC and 250 VS participants at study entry and 1 mo following randomization. Higher levels of hsCRP, IL-6, and D-dimer at study entry were significantly associated with an increased risk of all-cause mortality. Unadjusted ORs (highest versus lowest quartile) were 2.0 (95% confidence interval [CI], 1.0-4.1; p = 0.05), 8.3 (95% CI, 3.3-20.8; p < 0.0001), and 12.4 (95% CI, 4.2-37.0; p < 0.0001), respectively. Associations were significant after adjustment, when the DC and VS groups were analyzed separately, and when latest levels were assessed. IL-6 and D-dimer increased at 1 mo by 30% and 16% in the DC group and by 0% and 5% in the VS group (p < 0.0001 for treatment difference for both biomarkers); increases in the DC group were related to HIV-RNA levels at 1 mo (p < 0.0001). In an expanded case-control analysis (four controls per case), the OR (DC/VS) for mortality was reduced from 1.8 (95% CI, 1.1-3.1; p = 0.02) to 1.5 (95% CI, 0.8-2.8) and 1.4 (95% CI, 0.8-2.5) after adjustment for latest levels of IL-6 and D-dimer, respectively. CONCLUSIONS: IL-6 and D-dimer were strongly related to all-cause mortality. Interrupting ART may further increase the risk of death by raising IL-6 and D-dimer levels. Therapies that reduce the inflammatory response to HIV and decrease IL-6 and D-dimer levels may warrant investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.0050203

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Exploratory Data Analysis
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,707
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Exploratory Data Analysis.
Birch, J. B., & Tukey, J. W. (1978) · Journal of the American Statistical Association · doi:10.2307/2286300 · Cited by 1,465
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women
Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B. L., Merz, C. N. B., Sopko, G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115516.54550.b1 · Cited by 417
Problems due to Small Samples and Sparse Data in Conditional Logistic Regression Analysis
Greenland, S., Schwartzbaum, J., & Finkle, W. D. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010240 · Cited by 367

Flagged first, then by citations

Show all 42 references

1 of the 42 references couldn’t be matched to a known paper.

Research works printed but not linked: 38

De Larrangas, 2003, Blood Coagul Fibrinolysis, 14, 15
Torriani, 2008, J Am Coll Cardiol, 52, 569
Solages, 2006, Clin Infect Dis, 42, 1325
Lekakis, 2007, Euro Heart J (Suppl 1), 28, P2870
Wolf, 2002, J Infect Dis, 185, 456
Aziz, 1998, Clin Diagn Lab Immunol, 5, 755
Dolan, 2006, J Acquir Immune Defic Syndr, 39, 44
Lederman, 2000, AIDS, 14, 951
Lau, 2006, Arch Intern Med, 166, 64
Lifson, 2008, HIV Clin Trials, 9, 177
Sakkinen, 1999, Am J Epidemiol, 149, 261
Kuller, 1996, Am J Epidemiol, 144, 537
Johnson, 2004, Circulation, 109, 726
Harris, 1999, Am J Med, 106, 506
Ridker, 2000, Circulation, 101, 1767
Jenny, 2007, Arterioscler Thromb Vasc Biol, 27, 352
Danesh, 1999, Eur Heart J, 20, 954
Folsom, 2001, Thromb Haemost, 86, 366
Cushman, 1999, Arterioscler Thromb Vasc Biol, 19, 493
Danesh, 2001, Circulation, 103, 2323
Kooperberg, 2007, PLoS Clin Trials, 2
Cohen, 2003, Am J Med, 114, 180
Smith, 2005, Circulation, 112, 3080
Zakai, 2007, J Thromb Haemost, 5, 1128
Sasieni, 1992, Stat Med, 11, 617
Greenland, 2000, Am J Epidemiol, 151, 531
Peduzzi, 1996, J Clin Epidemiol, 49, 1373
Lowe, 2005, Semin Vasc Med, 5, 387
Lau, 2007, J Acquir Immune Defic Syndr, 44, 179
Shorr, 2002, CHEST, 121, 1262
Maldarelli, 2007, PLoS Pathog, 3, 484
Birdsall, 2002, AIDS, 16, 5
Brenchley, 2006, Nature Med, 12, 1365
Derhaschnig, 2004, Crit Care Med, 32, 1136
Boos, 2007, Am J Cardiol, 100, 986
Li, 2004, J Infect Dis, 189, 572
Decrion, 2005, Curr HIV Res, 3, 243
van Gorp, 1999, J Infect Dis, 180, 176

Sorted by citations

Items 601–700 of 1,000

Inflammation and pharmacokinetics: potential implications for HIV-infection
Seifert, S. M., Castillo‐Mancilla, J., Erlandson, K. M., & Anderson, P. L. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1311323 · Cited by 33
Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers
Sessa, L., Reddel, S., Manno, E. C., Quagliariello, A., Cotugno, N., CHIERICO, F. D., Amodio, D., Capponi, C., Leone, F., Bernardi, S., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002131 · Cited by 32
Adjunct Therapy for CD4+ T-Cell Recovery, Inflammation and Immune Activation in People Living With HIV: A Systematic Review and Meta-Analysis
Zhang, Y., Jiang, T., Li, A., Li, Z., Hou, J., Gao, M., Huang, X., Su, B., Wu, H., Zhang, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632119 · Cited by 32
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio
Saracino, A., Bruno, G., Scudeller, L., Volpe, A. R., Caricato, P., Ladisa, N., Monno, L., & Angarano, G. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0080 · Cited by 32
HIV infection and aging of the innate immune system
Hearps, A. C., Angelovich, T. A., Jaworowski, A., MILLS, J. S., LANDAY, A. L., & Crowe, S. M. (2011) · Sexual Health · doi:10.1071/sh11028 · Cited by 33
Lipodystrophy in HIV patients: its challenges and management approaches
Kotler, D. P., & Singhania, R. (2011) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s14562 · Cited by 32
Human immunodeficiency virus and menopause
Kanapathipillai, R., Hickey, M., & Giles, M. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318282aa57 · Cited by 32
HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL
Kelesidis, T., Yang, O. O., Currier, J. S., Navab, K. D., Fogelman, A. M., & Navab, M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-35 · Cited by 32
Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A crosssectional study
Gunda, D. W., Godfrey, K. G., Kilonzo, S. B., & Mpondo, B. C. T. (2017) · Malawi Medical Journal · doi:10.4314/mmj.v29i1.9 · Cited by 32
Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa
Sivro, A., McKinnon, L. R., Yende‐Zuma, N., Gengiah, S., Samsunder, N., Karim, S. S. A., & Naidoo, K. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix357 · Cited by 32
Role of Interleukin-2 in Patients with HIV Infection
Pett, S. L., Kelleher, A. D., & Emery, S. (2010) · Drugs · doi:10.2165/10898620-000000000-00000 · Cited by 31
Combination Antiretroviral Therapy With Raltegravir Leads to Rapid Immunologic Reconstitution in Treatment-Naive Patients With Chronic HIV Infection
Pallikkuth, S., Fischl, M. A., & Pahwa, S. G. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit387 · Cited by 33
Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
Chastain, D. B., Henderson, H. M., & Stover, K. R. (2015) · The Open AIDS Journal · doi:10.2174/1874613601509010023 · Cited by 32
Cardiac Disease Associated with Human Immunodeficiency Virus Infection
Bloomfield, G. S., & Leung, C. L. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2016.09.003 · Cited by 31
Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial
Gimbel, S., Mocumbi, A. O., Ásbjörnsdóttir, K., Coutinho, J., Andela, L., Cebola, B. R., Craine, H., Crocker, J., Hicks, L., Holte, S., et al. (2020) · Implementation Science · doi:10.1186/s13012-020-0973-4 · Cited by 31
The Effect of Antiretroviral Therapy on IL-6, IL-1β, TNF-α, IFN-γ Levels and their Relationship with HIV-RNA and CD4+ T Cells in HIV Patients
Okay, G., Koç, M. M., Güler, E. M., Yabacı, A., Koçyiğit, A., & Akkoyunlu, Y. (2020) · Current HIV Research · doi:10.2174/1570162x18666200712174642 · Cited by 31
Lung function abnormalities in HIV ‐infected adults and children
Calligaro, G., & Gray, D. M. (2014) · Respirology · doi:10.1111/resp.12385 · Cited by 31
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease
Borges, Á. H., Weitz, J. I., Collins, G., Baker, J. V., Lévy, Y., Davey, R. T., Phillips, A. N., Neaton, J. D., Lundgren, J. D., & Deeks, S. G. (2014) · AIDS · doi:10.1097/qad.0000000000000344 · Cited by 31
Deteriorating renal function and clinical outcomes in HIV-positive persons
Mocroft, A., Ryom, L., Begovać, J., Monforte, A. D., Vassilenko, A., Gatell, J. M., Florence, É., Ormaasen, V., Kirk, O., & Lundgren, J. D. (2013) · AIDS · doi:10.1097/qad.0000000000000134 · Cited by 31
von Willebrand Factor is elevated in HIV patients with a history of thrombosis
van den Dries, L. V. D., Gruters, R., der Borden, S. B. C. H.-V., Kruip, M., de Maat, M. D., van Gorp, E. V., & van der Ende, M. E. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00180 · Cited by 28
High Retention in Care Among HIV-Infected Patients Entering Care With CD4 Levels >350 cells/μL Under Routine Program Conditions in Uganda
Namusobya, J., Semitala, F. C., Amanyire, G., Kabami, J., Chamie, G., Bogere, J., Jain, V., Clark, T. D., Charlebois, E. D., Havlir, D. V., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit490 · Cited by 31
Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
Boyd, M. A., Mocroft, A., Ryom, L., Monforte, A. D., Sabin, C. A., El-Sadr, W. M., Hatleberg, C. I., Wit, S. D., Weber, R. K., Fontas, É., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002424 · Cited by 32
Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression
Castillo‐Mancilla, J., Morrow, M., Boum, Y., Byakwaga, H., Haberer, J. E., Martin, J. N., Bangsberg, D. R., MaWhinney, S., Musinguzi, N., Huang, Y., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001629 · Cited by 31
Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study
Peyracchia, M., LIO, G. D., Montrucchio, C., Omedè, P., d’Ettore, G., Calcagno, A., Vullo, V., Cerrato, E., Pennacchi, M., Sardella, G., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.001 · Cited by 31
Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV ‐infected individuals
Lucas, G., Cozzi‐Lepri, A., Wyatt, C., Post, F. A., Bormann, A., Crum‐Cianflone, N. F., Ross, M., & INSIGHT SMART Study Group (2013) · HIV Medicine · doi:10.1111/hiv.12087 · Cited by 30
The Effect of HIV Infection, Immunodeficiency, and Antiretroviral Therapy on the Risk of Hepatic Dysfunction
Towner, W. J., Xu, L., Leyden, W. A., Horberg, M. A., Chao, C., Tang, B. T., Klein, D. B., Hurley, L. B., Quesenberry, C. P., & Silverberg, M. J. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31824e9ef2 · Cited by 30
MicroRNA-210, MicroRNA-331, and MicroRNA-7 Are Differentially Regulated in Treated HIV-1–Infected Individuals and Are Associated With Markers of Systemic Inflammation
Ballegaard, V., Ralfkiær, U., Pedersen, K. K., Hove‐Skovsgaard, M., Koplev, S., Brændstrup, P., Ryder, L. P., MADSEN, H. O., Gerstoft, J., Grønbæk, K., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001191 · Cited by 30
Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV
Jan, A. K., Moore, J. V., Wang, R. J., McGing, M., Farr, C. K., Moisi, D. D., Hartman-Filson, M., Kerruish, R., Jeon, D., Lewis, E., et al. (2021) · AIDS · doi:10.1097/qad.0000000000002846 · Cited by 31
Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
Ellis, R. J., Wilson, N., & Peterson, S. N. (2021) · Viruses · doi:10.3390/v13081521 · Cited by 33
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART
Pino, M., Ribeiro, S. P., Pagliuzza, A., Ghneim, K., Khan, A. N., Ryan, E. S., Harper, J. L., King, C. T., Welbourn, S., Micci, L., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009825 · Cited by 30
The CD8+HLA‐DR+ T cells expanded in HIV‐1 infection are qualitatively identical to those from healthy controls
Imamichi, H., Lempicki, R. A., Adelsberger, J. W., Hasley, R. B., Rosenberg, A., Roby, G. A., Rehm, C. A., Nelson, A. K., Krishnan, S., Pavlick, M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142046 · Cited by 30
Dynamics of Regulatory T-Cells during Pregnancy: Effect of HIV Infection and Correlations with Other Immune Parameters
Richardson, K. M., & Weinberg, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028172 · Cited by 30
N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients
Duprez, D. A., Neuhaus, J., Tracy, R. P., Kuller, L. H., Deeks, S. G., Orkin, C. M., Stoehr, A. D., Woolley, I. J., & Neaton, J. D. (2011) · AIDS · doi:10.1097/qad.0b013e32834404a1 · Cited by 30
Cardiovascular disease in patients with chronic human immunodeficiency virus infection
Escarcega, R. O., Franco, J. J., Mani, B. C., Vyas, A. V., Tedaldi, E., & Bové, A. A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.155 · Cited by 31
Omega-3 Fatty Acids Do Not Improve Endothelial Function In Virologically Suppressed HIV-Infected Men: A Randomized Placebo-Controlled Trial
Hileman, C. O., Carman, T. L., Storer, N. J., Labbato, D. E., White, C. A., & McComsey, G. A. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0088 · Cited by 30
HIV Replication, Inflammation, and the Effect of Starting Antiretroviral Therapy on Plasma Asymmetric Dimethylarginine, a Novel Marker of Endothelial Dysfunction
Baker, J. V., Neuhaus, J., Duprez, D. A., Freiberg, M. S., Bernardino, J. I., Badley, A. D., Nixon, D. E., Lundgren, J. D., Tracy, R. P., & Neaton, J. D. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318252f99f · Cited by 30
Reconstitution of CD4 T Cells in Bronchoalveolar Lavage Fluid after Initiation of Highly Active Antiretroviral Therapy
Knox, K. S., Vinton, C. L., Hage, C. A., Kohli, L. L., Twigg, H. L., Klatt, N. R., Zwickl, B., Waltz, J., Goldman, M., Douek, D. C., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01138-10 · Cited by 30
Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients
Vispo, E., Çevik, M., Rockstroh, J. K., Barreiro, P., Nelson, M. R., Scourfield, A., Boesecke, C., Wasmuth, J., & Soriano, V. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit001 · Cited by 31
Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection
Graham, S. M., Mwilu, R., & Liles, W. C. (2013) · Virulence · doi:10.4161/viru.25221 · Cited by 30
MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection
Huang, J., Zhu, L., Qiu, C., Xu, X., Zhang, L., Ding, X., Liao, Q., Xu, J., & Zhang, X. (2017) · Journal of Virology · doi:10.1128/jvi.02048-16 · Cited by 32
Longitudinal Study of Falls among HIV-Infected and Uninfected Women: The Role of Cognition
Sharma, A., Hoover, D. R., Shi, Q., Holman, S., Plankey, M. W., Tien, P. C., Weber, K. M., Floris-Moore, M., Bolívar, H., Vance, D. E., et al. (2017) · Antiviral Therapy · doi:10.3851/imp3195 · Cited by 30
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy
Angelidou, K., Hunt, P. W., LANDAY, A. L., Wilson, C. C., Rodriguez, B. A., Deeks, S. G., Bosch, R. J., & Lederman, M. M. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix666 · Cited by 30
A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy
Yi, T. J., Walmsley, S. L., Szadkowski, L., Raboud, J., Rajwans, N., Shannon, B., Kumar, S. A., Kain, K. C., Kaul, R., & Tan, D. H. S. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit539 · Cited by 29
Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV
Cioe, P. A., Baker, J. V., Kojic, E. M., Önen, N. F., Hammer, J., Patel, P., & Kahler, C. W. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000759 · Cited by 29
Cardiovascular Disease, Statins, and HIV
Eckard, A. R., Meissner, E. G., Singh, I., & McComsey, G. A. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw288 · Cited by 29
HIV Therapy—The State of ART
Looney, D. J., Ma, A., & Johns, S. T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_440 · Cited by 29
Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis
Colomb, F., Giron, L. B., Trbojević‐Akmačić, I., Lauc, G., & Abdel‐Mohsen, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00433-w · Cited by 28
Good Fences Make Good Neighbors: Human Immunodeficiency Virus and Vascular Disease
Mayne, E. S., & Louw, S. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz303 · Cited by 29
Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection
Ferrari, B., Silva, A. C. D., Liu, K., Saidakova, E. V., Korolevskaya, L. B., Shmagel, K. V., Shive, C. L., Sánchez, G. P., Retuerto, M., Sharma, A. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci149571 · Cited by 29
New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals
Martin, H. A., Kadiyala, G. N., Telwatte, S., Wedrychowski, A., Chen, T., Morón‐López, S., Arneson, D., Hoh, R., Deeks, S. G., Wong, J. K., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01605-22 · Cited by 29
Reduced Immune Activation During Tenofovir–Emtricitabine Therapy in HIV-Negative Individuals
Castillo‐Mancilla, J., Meditz, A. L., Wilson, C. C., Zheng, J., Palmer, B. E., Lee, E. J., Gardner, E. M., Seifert, S. M., Kerr, B. J., Bushman, L. R., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000529 · Cited by 29
Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study
Tan, D. H. S., Raboud, J., Kaul, R., & Walmsley, S. L. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004210 · Cited by 29
HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations
Teer, E., Joseph, D. E., Driescher, N., Nell, T. A., Dominick, L., Midgley, N., Deshpande, G., Page, M. J., Pretorius, E., Woudberg, N. J., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00797.2018 · Cited by 29
Impact of HIV status on systemic inflammation during pregnancy
Vyas, P., Mathad, J. S., Leu, C., Naik, S., Alexander, M., Araújo‐Pereira, M., Kulkarni, V., Deshpande, P., Yadana, S., Andrade, B. B., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003016 · Cited by 28
HIV infection and glycemic response to newly initiated diabetic medical therapy
Han, J., Crane, H. M., Bellamy, S. L., Frank, I., Cardillo, S., & Bisson, G. P. (2012) · AIDS · doi:10.1097/qad.0b013e328359a8e5 · Cited by 28
Acute coronary syndromes in patients with HIV
Seecheran, V. K., Giddings, S., & Seecheran, N. A. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000450 · Cited by 28
HIV-positive youth who are perinatally infected have impaired endothelial function
Dirajlal‐Fargo, S., Sattar, A., Kulkarni, M., Bowman, E., Funderburg, N., & McComsey, G. A. (2017) · AIDS · doi:10.1097/qad.0000000000001556 · Cited by 28
HIV infection is associated with thoracic and abdominal aortic aneurysms: a prospective matched cohort study
Høgh, J., Pham, M. H. C., Knudsen, A. D., Thudium, R. F., Gelpi, M., Sigvardsen, P. E., Fuchs, A., Kühl, J. T., Afzal, S., Nordestgaard, B. G., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab348 · Cited by 28
HIV is associated with thrombophilia and high D-dimer in children and adolescents
Pontrelli, G., Martino, A. M., Tchidjou, H. K., Citton, R., Mora, N., Ravà, L., Tozzi, A. E., Palma, P., Muraca, M., Franco, E., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328337b9a0 · Cited by 28
Potential Implication of Residual Viremia in Patients on Effective Antiretroviral Therapy
Sahu, G. K. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0194 · Cited by 28
Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers
Kim, C. J., Rousseau, R. K., Huibner, S., Kovacs, C. M., Benko, E., Shahabi, K., Kandel, G. P., Ostrowski, M., & Kaul, R. (2017) · AIDS · doi:10.1097/qad.0000000000001515 · Cited by 28
The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy
Sortino, O., Hullsiek, K. H., Richards, E. S., Rupert, A. W., Schminke, A., Tetekpor, N., Quiñones, M., Prosser, R. A., Schacker, T., Sereti, I., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz042 · Cited by 28
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management
Nazari, I. S., & Feinstein, M. J. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00098-22 · Cited by 29
Can HIV be cured with stem cell therapy?
Deeks, S. G., & McCune, J. M. (2010) · Nature Biotechnology · doi:10.1038/nbt0810-807 · Cited by 27
Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study
Peters, L., Neuhaus, J., Duprez, D. A., Neaton, J. D., Tracy, R. P., Klein, M. B., Mocroft, A., Rockstroh, J. K., Dore, G. J., & Lundgren, J. D. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.017 · Cited by 28
Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression
Thiébaut, R., Charpentier, C., Damond, F., Taïeb, A., Rachas, A., Capeau, J., Chêne, G., Collin, G., Matheron, S., Descamps, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis708 · Cited by 27
Trilobatin as an HIV ‐1 entry inhibitor targeting the HIV ‐1 Gp41 envelope
Yin, S., Zhang, X., Lai, F., Liang, T., Wen, J., Lin, W., Qiu, J., Liu, S., & Lin, L. (2018) · FEBS Letters · doi:10.1002/1873-3468.13113 · Cited by 27
Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus
Schnittman, S. R., Deitchman, A. N., Beck‐Engeser, G., Ahn, H., York, V. A., Hartig, H. M., Hecht, F. M., Martin, J. N., Deeks, S. G., Aweeka, F. T., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa580 · Cited by 30
Cystatin C and Baseline Renal Function Among HIV-Infected Persons in the SUN Study
Overton, E. T., Patel, P., Mondy, K. E., Bush, T. J., Conley, L. J., Rhame, F. S., Kojic, E. M., Hammer, J., Henry, K., & Brooks, F. T. S. S. I. J. T. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0018 · Cited by 27
Pentoxifylline, Inflammation, and Endothelial Function in HIV-Infected Persons: A Randomized, Placebo-Controlled Trial
Gupta, S. K., Mi, D., Dubé, M. P., Saha, C., Johnson, R. M., Stein, J. H., Clauss, M. A., Mather, K. J., Desta, Z., & Liu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060852 · Cited by 27
HIV Infection Is Associated With Decreased Thrombin Generation
Hsue, P. Y., Scherzer, R., Grünfeld, C., Nordstrom, S. M., Schnell, A., Kohl, L. P., Nitta, E. M., Martin, J. N., Deeks, S. G., & Weiss, E. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis014 · Cited by 27
HIV infection, aging and cardiovascular disease: epidemiology and prevention
Petoumenos, K., & Worm, S. W. (2011) · Sexual Health · doi:10.1071/sh11020 · Cited by 30
Association of HIV and Opportunistic Infections With Incident Stroke: A Nationwide Population-Based Cohort Study in Taiwan
Yen, Y., Chen, M., Jen, I.-A., Lan, Y., Chuang, P., Liu, Y.-L., Lee, Y. J., & Chen, Y. A. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001216 · Cited by 27
Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review
Vos, A. G., Hulzebosch, A., Grobbee, D. E., Barth, R. E., & Klipstein‐Grobusch, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169986 · Cited by 27
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone
Utay, N. S., Kitch, D. W., Yeh, E., Fichtenbaum, C. J., Lederman, M. M., Estes, J. D., Deléage, C., Magyar, C. E., Nelson, S. D., Klingman, K. L., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy064 · Cited by 27
Current Scenario and Strategies to Tackle Cardiovascular Disease Risk in HIV Geriatrics
Shabil, M., Kumar, V., Dhingra, S., Ravichandiran, V., Parihar, V. K., Kumar, N., Pandey, K., & Murti, K. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00332-0 · Cited by 27
Systemic and intrathecal immune activation in association with cerebral and cognitive outcomes in paediatric HIV
Blokhuis, C., Peeters, C. F. W., Cohen, S., Scherpbier, H. J., Kuijpers, T. W., Reiss, P., Kootstra, N. A., Teunissen, C. E., & Pajkrt, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-44198-z · Cited by 26
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection
Funderburg, N., Shive, C. L., Chen, Z., Tatsuoka, C. M., Bowman, E., Longenecker, C. T., McComsey, G. A., Clagett, B. M., Dorazio, D., Freeman, M. L., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad199 · Cited by 26
A Randomized, Placebo Controlled, Double Masked Phase IB Study Evaluating the Safety and Antiviral Activity of Aprepitant, a Neurokinin-1 Receptor Antagonist in HIV-1 Infected Adults
Tebas, P., Tuluc, F., Barrett, J. S., Wagner, W., Kim, D., Zhao, H., Gonin, R., Korelitz, J., & Douglas, S. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024180 · Cited by 27
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions
Bunupuradah, T., Duong, T., Compagnucci, A., McMaster, P., Bernardi, S., Kanjanavanit, S., Rampon, O., Faye, A., Saïdi, Y., Riault, Y., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835c1181 · Cited by 26
The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation
Wallet, M. A., Reist, C. M., Williams, J., Appelberg, S., Guiulfo, G., Gardner, B., Sleasman, J. W., & Goodenow, M. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911447 · Cited by 26
A cure for HIV: is it in sight?
Pace, M. J., & Frater, J. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.910112 · Cited by 26
Frequency and Risk Factors for Cerebral Arterial Disease in a HIV/AIDS Neuroimaging Cohort
Edwards, N. J., Grill, M. F., Choi, H. A., & Ko, N. (2016) · Cerebrovascular Diseases · doi:10.1159/000442755 · Cited by 26
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
Hove‐Skovsgaard, M., Gaardbo, J. C., Kolte, L., Winding, K. M., Seljeflot, I., Svardal, A. M., Berge, R. K., Gerstoft, J., Ullum, H., Trøseid, M., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2334-8 · Cited by 27
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study
Kovari, H., Calmy, A., Doco‐Lecompte, T., Nkoulou, R. N., Marzel, A., Weber, R. K., Kaufmann, P. A., Buechel, R. R., Ledergerber, B., TARR, P. E., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz283 · Cited by 26
Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults
Morse, C. G., Dodd, L. E., Nghiem, K., Costello, R., Csako, G., Lane, H. C., Lozier, J. N., & Kovacs, J. A. (2013) · AIDS · doi:10.1097/qad.0b013e32835c206a · Cited by 24
Effects of Probiotics on Diarrhea and CD4 Cell Count in People Living With HIV: A Systematic Review and Meta-Analysis
Zhang, X.-L., Chen, M.-H., Geng, S.-T., Yu, J., Kuang, Y.-Q., Luo, H.-Y., & Wang, K.-H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.570520 · Cited by 25
A Pilot Study of Telmisartan for Visceral Adiposity in HIV Infection: The Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial
Lake, J. E., Tseng, C., & Currier, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058135 · Cited by 25
Association between alcohol use and inflammatory biomarkers over time among younger adults with HIV—The Russia ARCH Observational Study
So‐Armah, K., Cheng, D. M., Freiberg, M. S., Gnatienko, N., Patts, G. J., Ma, Y., White, L. F., Blokhina, E. A., Lioznov, D. A., Doyle, M. F., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219710 · Cited by 25
Biomarkers panels can predict fatigue, depression and pain in persons living with HIV: A pilot study.
Zuñiga, J., Harrison, M., Henneghan, A. M., García, A. A., & Kesler, S. (2019) · Applied Nursing Research · doi:10.1016/j.apnr.2019.151224 · Cited by 23
Novel Strategies to Combat CMV-Related Cardiovascular Disease
Vasilieva, E., Gianella, S., & Freeman, M. L. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.382 · Cited by 27
β-Catenin Regulates Wound Healing and IL-6 Expression in Activated Human Astrocytes
Edara, V. V., Nooka, S., Proulx, J., Stacy, S., Ghorpade, A., & Borgmann, K. (2020) · Biomedicines · doi:10.3390/biomedicines8110479 · Cited by 25
Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy
Chammartin, F., Lodi, S., Logan, R. W., Ryom, L., Mocroft, A., Kirk, O., Monforte, A. D., Reiss, P., Phillips, A. N., El‐Sadr, W., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5226 · Cited by 25
Mechanisms and primary prevention of atherosclerotic cardiovascular disease among people living with HIV
Durstenfeld, M. S., & Hsue, P. Y. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000681 · Cited by 26
Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression
Ngcobo, S. P., Molatlhegi, R. P., Osman, F., Ngcapu, S., Samsunder, N., Garrett, N., Karim, S. S. A., Karim, Q. A., McKinnon, L. R., & Sivro, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-06532-w · Cited by 24
The Determinants of Poor Respiratory Health Status in Adults Living with Human Immunodeficiency Virus Infection
Leung, J. M., Liu, J. C., Mtambo, A., Ngan, D., Nashta, N. F., Guillemi, S. A., Harris, M., Lima, V. D., Mattman, A., Shaipanich, T., et al. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0373 · Cited by 25
HIV and coronary arterial remodeling from the Multicenter AIDS Cohort Study (MACS)
Miller, P. E., Haberlen, S., Metkus, T. S., Rezaeian, P., Palella, F. J., Kingsley, L., Witt, M. D., George, R. T., Jacobson, L. P., Brown, T. T., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.022 · Cited by 25
Human Herpesvirus Replication and Abnormal CD8+ T Cell Activation and Low CD4+ T Cell Counts in Antiretroviral-Suppressed HIV-Infected Patients
Jacobson, M. A., Dittmer, D. P., Sinclair, E., Martin, J. N., Deeks, S. G., Hunt, P. W., Mocarski, E. S., & Shiboski, C. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005277 · Cited by 25
The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients
Kjær, A. S. H. K., Brinkmann, C. R., Dinarello, C. A., Olesen, R., Østergaard, L. J., Søgaard, O. S., Tolstrup, M., & Rasmussen, T. A. (2015) · AIDS · doi:10.1097/qad.0000000000000678 · Cited by 25
Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy
Zhao, H. H., & Goetz, M. B. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr058 · Cited by 25

Authors: Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., Paton, N. I., Neaton, J. D., & for the INSIGHT SMART Study Group
Affiliations: University of Pittsburgh (US)
University of Vermont (US)
Hospital Italiano de Buenos Aires (AR)
UNSW Sydney (AU)
National Institutes of Health (US)
University Hospital Zurich (CH)
University of Copenhagen (DK)
University of Minnesota (US)
Virginia Commonwealth University (US)
Medical Research Council (GB)
Corresponding author: Neaton, James D
ORCID: Kuller, Lewis H
Tracy, Russell
Belloso, Waldo
Drummond, Fraser
Lane, H. Clifford
Ledergerber, Bruno
Lundgren, Jens
Paton, Nicholas I
Neaton, James D
Venue: PLoS Medicine
Publisher: Public Library of Science (PLoS)
Published: 2008-10-21
Volume: 5
Issue: 10
Pages: e203
ISSN: 1549-1277 (ISSN-L)
1549-1676
DOI: 10.1371/journal.pmed.0050203
PMC: PMC2570418
OpenAlex: W2153136696
Cited by: 1,617
References: 42
Citations by year: 2026: 40 · 2025: 42 · 2024: 57 · 2023: 56 · 2022: 70 · 2021: 77 · 2020: 98 · 2019: 82 · 2018: 105 · 2017: 86 · 2016: 120 · 2015: 129 · 2014: 146 · 2013: 142 · 2012: 118
FWCI: 53.14
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS Medicine (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by)
Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, cc-by)
National University of Singapore (submittedVersion)
VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, public-domain)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
Zurich Open Repository and Archive (University of Zurich)
Funders: Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Gilead Sciences
Wake Forest University
Johns Hopkins University
National Institutes of Health
National Institute of Allergy and Infectious Diseases (U01 AI46362, U01AI046362, U01AI042170)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: HIV infection, all-cause mortality, inflammatory markers, coagulation markers, C-reactive protein, interleukin-6, D-dimer, prothrombin fragment 1+2, amyloid A, antiretroviral therapy interruption, viral rebound, thrombosis, fibrinolysis, tissue factor
MeSH terms: Serum Amyloid P-Component, Serum Amyloid A Protein, Blood Coagulation, C-Reactive Protein, Cause of Death, Female, Fibrin Fibrinogen Degradation Products, Follow-Up Studies, Humans, Inflammation, Male, Multicenter Studies as Topic, Biomarkers, HIV Infections, Interleukin-6, Survival Rate, Logistic Models, Odds Ratio, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Anti-HIV Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks